All stock lists
Equity Residential (New York Stock Exchange:EQR)
US · Delayed Price · Currency is USD
Also listed: 0IIB.L, VMRKReal Estate · REIT - Residential
$63.66-$2.31 (-3.50%)
Market cap
$23.9B
Insider Score
Health Score
Analyst consensus
Listed since
Aug 12, 1993
Website
Insider Score
––Not scored
EQR Insider Score
No insider has filed an open-market purchase or sale here in the last 90 days, so there is nothing to score yet.
Financial Health Score
Sound
From EQR’s reported statements · Q3 2026 (trailing 12 months) · 4 of 5 pillars
Profitability8 / 20
Loses money on what it sells.
- Revenue
- $3.55B
- Net income
- -$148.8M
- Net margin
- -4.2%
Leverage20 / 20
Little or no net debt.
- Total debt
- $0
- Cash
- $111.9M
- Net debt / EBITDA
- -0.05x
Liquidity—
Current assets or liabilities not reported.
- Current assets
- $111.9M
- Current liabilities
- $0
- Current ratio
- —
Cash generation20 / 20
The business funds itself from operations.
- Operating cash flow
- $1.43B
- Free cash flow
- $1.06B
- FCF margin
- 29.8%
Dilution & runway0 / 20
Heavy dilution — shareholders are paying for the business.
- Shares outstanding
- 585.4M
- Share growth (1y)
- 50.3%
Five pillars — profitability, leverage, liquidity, cash generation, dilution & runway — each scored 0–20 from the company’s own income statement, balance sheet and cash-flow statement, then scaled to 100. A pillar the statements cannot answer is left out rather than guessed; fewer than three and no score is shown.
EQR Income Statement
| Fiscal Period | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 |
|---|---|---|---|---|---|---|
| Period Ending | Sep 30, 2026 | Jun 30, 2026 | Mar 31, 2026 | Dec 31, 2025 | Sep 30, 2025 | Jun 30, 2025 |
| Revenue | $1.20 B | $785.05 M | $779.85 M | $789.03 M | $782.41 M | $768.83 M |
| Revenue Growth (YoY) | 52.79 % | 2.11 % | 2.50 % | 2.90 % | 4.55 % | 4.72 % |
| Cost of Revenue | $464.32 M | $303.16 M | $301.82 M | $803.27 M | $286.54 M | $283.39 M |
| Gross Profit | $731.16 M | $481.89 M | $478.02 M | -$14.23 M | $495.87 M | $485.44 M |
| SG&A Expense | $118.31 M | $16.64 M | $16.86 M | $0.00 | $14.66 M | $18.53 M |
| R&D Expense | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Operating Expenses | $118.31 M | $263.02 M | $264.36 M | -$237.16 M | $269.32 M | $259.42 M |
| Operating Income | $612.86 M | $218.87 M | $213.66 M | $222.92 M | $226.55 M | $226.01 M |
| Pretax Income | -$747.81 M | $118.15 M | $95.56 M | $391.86 M | $297.26 M | $204.20 M |
| Tax Provision | -$12.66 M | $411.00 K | $2.46 M | $361.00 K | $395.00 K | $5.40 M |
| Net Income | -$735.15 M | $114.14 M | $90.08 M | $382.09 M | $289.05 M | $192.36 M |
| EPS (Basic) | -$1.27 | $0.30 | $0.24 | $1.01 | $0.76 | $0.51 |
| EPS (Diluted) | -$1.27 | $0.30 | $0.24 | $1.00 | $0.74 | $0.50 |
| Shares Outstanding | 585.44 M | 382.41 M | 375.64 M | 379.12 M | 389.45 M | 389.84 M |
Quarterly figures; YoY compares the same fiscal quarter a year earlier. Source: public market data.
Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.